Lilly Ventures and Novartis Venture Fund have co-led a $26.1m round for Cavion, which is developing therapies for cancer and neurological diseases.

The marketing analytics company boosted its funding to $80m since 2006 in a round backed by corporate venturing unit American Family Ventures.

Care provider Ascension's corporate venturing unit invested in Reputation.com as part of a round that boosted its total funding to about $85m since 2006.

BlueCross BlueShield Venture Partners led a series E round that included existing backers American Express Ventures, Verizon Ventures and Rogers Venture Partners.

Existing investor Novo has taken part in a $28m round for Nerre Therapeutics, a GlaxoSmithKline spinout focusing on neuronal hypersensitivity treatments.

Merck & Co and General Electric have contributed to a $30m funding round for Arcadia Healthcare Solutions, a healthcare data analytics technology producer.

Takeda Pharmaceutical has signed a strategic agreement with PvP Biologics that gives the corporate an option to acquire the University of Washington spinout.

Seven members of digital health company iCarbonX's Digital Life Alliance have attracted almost $400m, with PatientsLikeMe raising $100m.

IDG Capital has contributed to a $22m funding round that will help fintech producer Huisuanzhang establish an accounting firm network and improve its products.